Abbott Entering Embolic Protection, Carotid Stent Markets Via MedNova
This article was originally published in The Gray Sheet
Executive Summary
Abbott Labs is anticipating FDA approval of MedNova's CardioShield embolic filter device for saphenous vein graft applications in 2003, following a Feb. 2 announcement of an exclusive worldwide distribution agreement between the companies.